Skip to content
MedsAcross

Molecule

Aceclidine

Also known as aceclidine hydrochloride
Available on requestCold chainOphthalmology
Presentations
1
Brands
1
Manufacturers
1
Available from stock
0

Aceclidine is a cholinergic receptor agonist indicated for the treatment of presbyopia in adults. It is available as eye drops for ophthalmic use. MedsAcross supplies Aceclidine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Key facts

Pharmacological class
Cholinergic Receptor Agonist, Cholinergic Muscarinic Agonists
ATC classification
S01EB08 Aceclidine · Eye medicines, subgroup S01E, subgroup S01EB
US FDA first approval
31 July 2025
EU status
Not recorded
Orphan designation
Not recorded
WHO essential medicine
Not recorded
India (CDSCO)
Not yet confirmed against CDSCO approval lists
Routes
Ophthalmic
Dosage forms
Eye drops
Identifiers
UNII 0578K3ELIOCAS 827-61-2DrugBank DB13262Q2362603

Clinical information

From the regulator-approved product information. Each section names its source.

Uses

VIZZ is indicated for the treatment of presbyopia in adults. VIZZ is a cholinergic agonist indicated for the treatment of presbyopia in adults.

Source: US FDA prescribing information

How it works

Aceclidine is a cholinergic muscarinic agonist that stimulates muscarinic receptors located on smooth muscles. VIZZ is a predominantly pupil selective miotic that interacts with the iris with minimal ciliary muscle stimulation. VIZZ causes contraction of the iris sphincter muscle, resulting in a pinhole effect that extends depth of focus to improve vision.

Source: US FDA prescribing information

Dosing overview

Instill one drop in each eye, wait 2 minutes and instill a second drop in each eye once daily. Recommended Dosage Instill one drop in each eye, wait 2 minutes and instill a second drop in each eye once daily from the same single-dose vial.

Source: US FDA prescribing information

Warnings and precautions

Blurred Vision: Patients may experience temporary dim or dark vision after instillation. Do not drive or operate machinery if vision is not clear (e.g., blurred vision). Exercise caution in night driving and other hazardous activities in poor illumination. Risk of Retinal Tear/Detachment: Rare cases of retinal tears and detachments have been reported with miotics. Examination of the retina is advised in all patients prior to initiation of therapy. Patients should be advised to seek immediate medical care with sudden onset of flashing lights, floaters, or vision loss. Iritis: Caution is advised in patients with a history of iritis.

Source: US FDA prescribing information

Side effects

The most common adverse reactions were instillation site irritation (20%), dim vision (16%), and headache (13%).

Source: US FDA prescribing information

Storage

Store refrigerated at 36°F to 46°F (2°C to 8°C). Do not freeze. When stored in refrigerated conditions, VIZZ can be used until the expiration date. Once pouch or vial(s) are removed from refrigeration, VIZZ may be stored at room temperature [up to 77°F (25°C)] but must be used within 30 days. During shipment, VIZZ may be maintained at temperatures up to 104°F (40°C) for a period not exceeding 8 days.

Source: US FDA prescribing information

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

All presentations

1 presentations of Aceclidine, sorted by availability.

MedicineManufacturerRegisterAvailability
Vizz 14.66 mg/mL eye dropsOphthalmic Cold chainLENZ TherapeuticsUS FDAAvailable on request

Brands by market

1 brand names across 1 markets.

Brand names by country

United States

Manufacturers

Regulatory status

Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.

RegisterStatusSource
US FDAFirst approved 31 July 2025Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Questions and answers

Is Aceclidine available for export from India?

Yes, on request. MedsAcross lists 1 presentations of Aceclidine and sources them for licensed hospitals, importers and physicians against valid import documents.

What brand names does Aceclidine have?

The catalogue lists 1 brand names for Aceclidine, including Vizz.

Is Aceclidine approved by the US FDA?

Yes. The US FDA first approved Aceclidine on 31 July 2025, according to Drugs@FDA.

Does Aceclidine need cold chain shipping?

At least one listed presentation of Aceclidine must be kept cold, so it is shipped in temperature-controlled packaging. Check the storage line on each presentation.

Which ATC class is Aceclidine in?

Aceclidine is classified under ATC code S01EB08 (Aceclidine).

References

  1. VIZZ prescribing information (LENZ Therapeutics). U.S. National Library of Medicine, DailyMed. Retrieved 14 January 2026

Request Aceclidine for export supply

Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.